This compound is a nucleoside phosphoramidite intermediate used in the production of oligonucleotides. It features a complex structure with multiple aromatic rings, ether linkages, and a cyanoethoxy phosphoramidite group, designed for solid-phase DNA/RNA synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 144089-97-4
5'-O-(4,4-Dimethoxytrityl)-2'-O-methyl-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
pharmaceutical intermediate
5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
pharmaceutical intermediate
N2-iBu-5'-O-DMTr-2'-O-hexadecanyl guanosine 3'-CED
pharmaceutical intermediate
2'-dG(iBu)-2'-phosphoramidite
pharmaceutical intermediate
Diphenyl-N-methyl-D-prolinol
pharmaceutical intermediate
Fmoc-L-Aspartic acid alpha-allyl ester
pharmaceutical intermediate
[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethylethyl ester
pharmaceutical intermediate
((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
KJFUMXZZVYMQEU-AOCJBPQJSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N)F